Lucid Diagnostics Inc.
LUCD
$1.39
$0.118.59%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 4.19M | 3.80M | 2.98M | 2.43M | 1.50M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.19M | 3.80M | 2.98M | 2.43M | 1.50M |
| Cost of Revenue | 6.41M | 6.36M | 6.30M | 5.98M | 6.14M |
| Gross Profit | -2.22M | -2.56M | -3.31M | -3.55M | -4.64M |
| SG&A Expenses | 35.37M | 34.11M | 32.90M | 35.66M | 37.57M |
| Depreciation & Amortization | 870.00K | 1.27M | 1.67M | 1.86M | 1.86M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 49.32M | 48.37M | 47.94M | 50.91M | 53.50M |
| Operating Income | -45.13M | -44.57M | -44.96M | -48.48M | -52.00M |
| Income Before Tax | -44.82M | -46.66M | -47.03M | -52.67M | -56.76M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -44.82 | -46.66 | -47.03 | -52.67 | -56.76 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -44.82M | -46.66M | -47.03M | -52.67M | -56.76M |
| EBIT | -45.13M | -44.57M | -44.96M | -48.48M | -52.00M |
| EBITDA | -43.56M | -42.58M | -42.57M | -45.98M | -49.52M |
| EPS Basic | -1.13 | -1.23 | -1.27 | -1.26 | -1.41 |
| Normalized Basic EPS | -0.60 | -0.63 | -0.66 | -0.74 | -0.83 |
| EPS Diluted | -1.13 | -1.23 | -1.27 | -1.26 | -1.41 |
| Normalized Diluted EPS | -0.60 | -0.63 | -0.66 | -0.74 | -0.83 |
| Average Basic Shares Outstanding | 185.95M | 177.44M | 171.06M | 167.01M | 162.05M |
| Average Diluted Shares Outstanding | 185.95M | 177.44M | 171.06M | 167.01M | 162.05M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
